Showing results (1-10 of 265) with videos related to
Sort By:
Pageof 27
Current Opinion in HIV and AIDS|March 8, 2024
New latency-promoting agents for a block-and-lock functional cure strategyEline Pellaers, Alexe Denis, Zeger DebyserViruses|January 21, 2023
Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV-Based Vectors and for a Cure for HIV-1 InfectionEline Pellaers, Anayat Bhat, Frauke Christ, et al.Nature Communications|May 7, 2025
BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcriptionEline Pellaers, Julie Janssens, Lore Wils, et al.Microbiology Spectrum|April 27, 2026
The LEDGIN GS-9822 inhibits HIV-2 infection and enhances HIV-2 latencyAnne Bruggemans, Gerlinde Vansant, Eline Pellaers, et al.Current Gene Therapy|December 20, 2003
A short course on virology / vectorology / gene therapyZeger DebyserExpert Opinion on Pharmacotherapy|August 2, 2012
Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDFRik Schrijvers, Zeger DebyserVirology|December 11, 2012
The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapyFrauke Christ, Zeger DebyserBiochemical and Biophysical Research Communications|September 12, 2006
The central DNA flap of the human immunodeficiency virus type 1 is important for viral replicationJan De Rijck, Zeger DebyserAIDS Reviews|May 7, 2005
HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteinsBénédicte Van Maele, Zeger DebyserPageof 27